3D Tumor Model May Lead to Improved Ovarian Cancer Treatment
Ovarian cancer treatments may be improved by lab grown three dimensional tumor model.
Related Articles
Cambrex Inks Deal with Lilly to Support Biotech Collaborator Manufacturing
The Cambrex Longmont facility reportedly offers all services required to advance early-stage small molecules into the clinic.
Online Event
Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics. But their complex structure poses significant development and safety challenges for biopharma. In this GEN…
AI Outperforms Experts in Neuroscience Study Predictions
AI’s predictive capabilities are increasing and perhaps surpassing human intuition in predicting the outcomes of neuroscience research.
Genomic Road Map Pinpoints Markers of Malaria Drug Resistance
Genomic analysis of malaria parasites reveals which genetic variants are most likely to confer resistance to antimalarial compounds.
Amgen Raises NC Investment to $1.5B with Plans for Second Plant
Amgen will raise its biomanufacturing investment in Holly Springs, NC, to $1.5 billion by establishing a second drug substance manufacturing plant there.
Lonza Expands Smart Capsule Offering for Companies Developing Oral Delivery Solutions for Biologic Drugs
Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.
Machine Learning Promises to Increase Cell Culture Productivity
Large datasets can be used by machine learning to make predictions for better choice of culture media conditions.
Parallel Pathway Leaves Long-Term Memory Unscathed Despite Short-Term Disruption in Mice
A new study in mice suggests an alternate pathway for forming long-term memories even when short-term memories fail to form.
Illumina’s Jacob Thaysen Describes His First Year as CEO
Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for…
Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing UBA1
Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.